Annual Current Assets
$14.56 M
-$21.77 M-59.92%
31 December 2023
Summary:
AIM ImmunoTech annual total current assets is currently $14.56 million, with the most recent change of -$21.77 million (-59.92%) on 31 December 2023. During the last 3 years, it has fallen by -$25.75 million (-63.89%). AIM annual current assets is now -75.08% below its all-time high of $58.40 million, reached on 31 December 2009.AIM Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$7.57 M
-$2.79 M-26.94%
30 September 2024
Summary:
AIM ImmunoTech quarterly total current assets is currently $7.57 million, with the most recent change of -$2.79 million (-26.94%) on 30 September 2024. Over the past year, it has dropped by -$15.17 million (-66.71%). AIM quarterly current assets is now -87.80% below its all-time high of $62.07 million, reached on 30 September 2009.AIM Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -59.9% | -66.7% |
3 y3 years | -63.9% | -80.1% |
5 y5 years | +283.1% | -40.0% |
AIM Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -71.0% | at low | -85.0% | at low |
5 y | 5 years | -71.0% | +283.1% | -85.2% | at low |
alltime | all time | -75.1% | +315.3% | -87.8% | +298.4% |
AIM ImmunoTech Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $7.57 M(-26.9%) |
June 2024 | - | $10.36 M(-8.4%) |
Mar 2024 | - | $11.31 M(-22.3%) |
Dec 2023 | $4.83 M(+15.8%) | $14.56 M(-36.0%) |
Sept 2023 | - | $22.74 M(-21.2%) |
June 2023 | - | $28.87 M(-12.9%) |
Mar 2023 | - | $33.16 M(-8.7%) |
Dec 2022 | $4.17 M(-44.3%) | $36.32 M(-11.7%) |
Sept 2022 | - | $41.15 M(-10.6%) |
June 2022 | - | $46.05 M(-8.6%) |
Mar 2022 | - | $50.38 M(+0.3%) |
Dec 2021 | $7.49 M(-69.2%) | $50.21 M(+32.0%) |
Sept 2021 | - | $38.04 M(-8.0%) |
June 2021 | - | $41.33 M(-19.3%) |
Mar 2021 | - | $51.22 M(+27.1%) |
Dec 2020 | $24.27 M(+135.5%) | $40.31 M(+1.4%) |
Sept 2020 | - | $39.76 M(+13.1%) |
June 2020 | - | $35.16 M(+18.4%) |
Mar 2020 | - | $29.71 M(+184.4%) |
Dec 2019 | $10.31 M(+2.6%) | $10.45 M(-17.2%) |
Sept 2019 | - | $12.62 M(+236.2%) |
June 2019 | - | $3.75 M(-35.9%) |
Mar 2019 | - | $5.86 M(+54.1%) |
Dec 2018 | $10.05 M(-6.1%) | $3.80 M(-23.1%) |
Sept 2018 | - | $4.94 M(-6.5%) |
June 2018 | - | $5.29 M(-6.7%) |
Mar 2018 | - | $5.66 M(+61.6%) |
Dec 2017 | $10.70 M(-10.3%) | $3.50 M(-6.2%) |
Sept 2017 | - | $3.73 M(-20.2%) |
June 2017 | - | $4.68 M(-9.8%) |
Mar 2017 | - | $5.19 M(-25.2%) |
Dec 2016 | $11.93 M(-2.5%) | $6.94 M(-25.6%) |
Sept 2016 | - | $9.33 M(-13.0%) |
June 2016 | - | $10.73 M(+12.5%) |
Mar 2016 | - | $9.54 M(-9.8%) |
Dec 2015 | $12.23 M(-5.4%) | $10.57 M(-24.4%) |
Sept 2015 | - | $13.98 M(-18.1%) |
June 2015 | - | $17.06 M(-4.8%) |
Mar 2015 | - | $17.92 M(+8.5%) |
Dec 2014 | $12.93 M(-2.9%) | $16.51 M(-6.6%) |
Sept 2014 | - | $17.67 M(-13.6%) |
June 2014 | - | $20.46 M(-6.5%) |
Mar 2014 | - | $21.89 M(+18.0%) |
Dec 2013 | $13.31 M(+2.7%) | $18.55 M(-37.2%) |
Sept 2013 | - | $29.55 M(-10.1%) |
June 2013 | - | $32.88 M(-14.8%) |
Mar 2013 | - | $38.58 M(-13.7%) |
Dec 2012 | $12.97 M(+10.6%) | $44.73 M(+22.7%) |
Sept 2012 | - | $36.45 M(+19.6%) |
June 2012 | - | $30.49 M(-9.4%) |
Mar 2012 | - | $33.64 M(+5.8%) |
Dec 2011 | $11.73 M(-21.9%) | $31.79 M(-7.1%) |
Sept 2011 | - | $34.22 M(+3.6%) |
June 2011 | - | $33.04 M(-9.9%) |
Mar 2011 | - | $36.67 M(0.0%) |
Dec 2010 | $15.01 M | $36.67 M(-4.9%) |
Sept 2010 | - | $38.56 M(+4.7%) |
June 2010 | - | $36.82 M(-31.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $53.99 M(-7.6%) |
Dec 2009 | $6.59 M(+11.7%) | $58.40 M(-5.9%) |
Sept 2009 | - | $62.07 M(+45.1%) |
June 2009 | - | $42.78 M(+540.5%) |
Mar 2009 | - | $6.68 M(-8.7%) |
Dec 2008 | $5.90 M(-9.9%) | $7.31 M(-18.8%) |
Sept 2008 | - | $9.01 M(-22.1%) |
June 2008 | - | $11.56 M(-17.9%) |
Mar 2008 | - | $14.09 M(-15.1%) |
Dec 2007 | $6.54 M(-20.1%) | $16.60 M(-14.0%) |
Sept 2007 | - | $19.30 M(-14.2%) |
June 2007 | - | $22.50 M(-14.1%) |
Mar 2007 | - | $26.20 M(+12.7%) |
Dec 2006 | $8.19 M(+27.1%) | $23.24 M(+13.5%) |
Sept 2006 | - | $20.48 M(-11.3%) |
June 2006 | - | $23.09 M(-10.5%) |
Mar 2006 | - | $25.79 M(+41.6%) |
Dec 2005 | $6.45 M(+7.4%) | $18.21 M(+32.9%) |
Sept 2005 | - | $13.70 M(-7.0%) |
June 2005 | - | $14.73 M(-12.3%) |
Mar 2005 | - | $16.79 M(-13.0%) |
Dec 2004 | $6.00 M(+25.1%) | $19.29 M(-9.4%) |
Sept 2004 | - | $21.28 M(+70.9%) |
June 2004 | - | $12.46 M(+19.3%) |
Mar 2004 | - | $10.44 M(+21.3%) |
Dec 2003 | $4.80 M(+190.6%) | $8.61 M(+6.8%) |
Sept 2003 | - | $8.06 M(+13.2%) |
June 2003 | - | $7.12 M(+3.2%) |
Mar 2003 | - | $6.90 M(+57.2%) |
Dec 2002 | $1.65 M(-48.9%) | $4.39 M(-0.7%) |
Sept 2002 | - | $4.42 M(-27.3%) |
June 2002 | - | $6.07 M(-19.3%) |
Mar 2002 | - | $7.53 M(-14.5%) |
Dec 2001 | $3.23 M(-19.7%) | $8.81 M(+98.7%) |
Sept 2001 | - | $4.43 M(-19.8%) |
June 2001 | - | $5.53 M(-17.7%) |
Mar 2001 | - | $6.72 M(-25.7%) |
Dec 2000 | $4.02 M(+27.0%) | $9.04 M(-4.3%) |
Sept 2000 | - | $9.46 M(-13.6%) |
June 2000 | - | $10.94 M(-11.4%) |
Mar 2000 | - | $12.35 M(+12.2%) |
Dec 1999 | $3.17 M(+21.8%) | $11.00 M(+39.2%) |
Sept 1999 | - | $7.90 M(-14.1%) |
June 1999 | - | $9.20 M(-17.9%) |
Mar 1999 | - | $11.20 M(-18.2%) |
Dec 1998 | $2.60 M(+85.7%) | $13.70 M(-11.6%) |
Sept 1998 | - | $15.50 M(+101.3%) |
June 1998 | - | $7.70 M(-12.5%) |
Mar 1998 | - | $8.80 M(-12.9%) |
Dec 1997 | $1.40 M(-12.5%) | $10.10 M(+431.6%) |
Sept 1997 | - | $1.90 M(-36.7%) |
June 1997 | - | $3.00 M(-28.6%) |
Mar 1997 | - | $4.20 M(-22.2%) |
Dec 1996 | $1.60 M(+23.1%) | $5.40 M(-20.6%) |
Sept 1996 | - | $6.80 M(+161.5%) |
June 1996 | - | $2.60 M(-29.7%) |
Mar 1996 | - | $3.70 M(-67.5%) |
Dec 1995 | $1.30 M | $11.40 M |
FAQ
- What is AIM ImmunoTech annual total current assets?
- What is the all time high annual current assets for AIM ImmunoTech?
- What is AIM ImmunoTech annual current assets year-on-year change?
- What is AIM ImmunoTech quarterly total current assets?
- What is the all time high quarterly current assets for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly current assets year-on-year change?
What is AIM ImmunoTech annual total current assets?
The current annual current assets of AIM is $14.56 M
What is the all time high annual current assets for AIM ImmunoTech?
AIM ImmunoTech all-time high annual total current assets is $58.40 M
What is AIM ImmunoTech annual current assets year-on-year change?
Over the past year, AIM annual total current assets has changed by -$21.77 M (-59.92%)
What is AIM ImmunoTech quarterly total current assets?
The current quarterly current assets of AIM is $7.57 M
What is the all time high quarterly current assets for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly total current assets is $62.07 M
What is AIM ImmunoTech quarterly current assets year-on-year change?
Over the past year, AIM quarterly total current assets has changed by -$15.17 M (-66.71%)